| 3.250 -0.130 (-3.85%) 03-11 17:35 |
|
| Open: | 3.400 |
| High: | 3.460 |
| Low: | 3.230 |
| Pre. close: | 3.380 |
| Volume: | 82,956 |
| Avg. volume: | 189,331 |
| MA (50): | 2.684 |
| MA (200): | 2.125 |
| Year high: | 5.100 |
| Year low: | 0.261 |
| Market cap: | 31(M) |
| EPS: | -0.34 |
| PE ratio: | -9.56 |
| SELL | BUY |
| HeikinAshi: | |
| Kaufmans AMA: | |
| Chandelier (20): | |
| MA (5): | |
| MA (50): | |
| MACD (26,12,9): | |
| Slow KDJ (14,3): | |
| RSI (14): | |
| CCI (20): |
Wed, 25 Feb 2026
Dentons advises Biocodex on a strategic licensing agreement with THX Pharma - Dentons
Thu, 19 Feb 2026
Thx Pharma : THX Pharma Reports Its Cash Position as of December 31, 2025 - marketscreener.com
Tue, 17 Feb 2026
THX Pharma appoints Julien Veys as Deputy CEO - PMLiVE
Wed, 11 Feb 2026
THX Pharma and Biocodex link up on rare diseases - The Pharma Letter
Wed, 11 Feb 2026
French biopharma duo THX Pharma and Biocodex strike rare diseases licensing deal worth up to €173M - European Biotechnology Magazine
Wed, 11 Feb 2026
THX Pharma and Biocodex Enter Licensing Agreemnt to Advance Two Drug Candidates Across Multiple Rare Diseases - Pharmaceutical Executive
©NovaStocks.com | euro Stocks quote, company news, stock charts, technical analysis. Data and information is provided for informational purposes only, is not intended for trading purposes and is not investment advice. Neither NovaStocks.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. Market data provided by: Financial Modeling Prep
Privacy Policy: Third parties, including Google, may be placing and reading cookies on your browsers, or other methods to collect information as a result of ad serving on this website. Third parties' use of advertising cookies enables it and its partners to serve ads to you based on your visit to this site and/or other sites on the Internet. You may opt out of personalized advertising by visiting Ads Settings. If you choose to use this website, you agree to the collection and use of information in relation to this policy. The information collected is used for providing and improving the ads Service. We will not use or share information with anyone, and we do not store any data from users.